Cipharm Côte d’Ivoire: Plans and Investment Opportunities

Ibrahim Diawara, President and CEO of Cipharm, gives an overview of the company’s future plans of launching a third unit to produce injectable medicines and doubling its turnover by 2020. Mr Diawara also talks about investment opportunities within Cipharm, saying that the company is open to offers from investors.

Ibrahim Diawara, President and CEO of , gives an overview of the company’s future plans of launching a third unit to produce injectable medicines and doubling its turnover by 2020. Mr Diawara also talks about investment opportunities within Cipharm, saying that the company is open to offers from investors.

Scroll to top
Close